← 홈

Antibody

168개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 168개
AntibodystaleHoffmann-La RochePhase 2

trastuzumab (Herceptin, ZN-A-1041 + PHESGO / Herceptin plus Perjeta injection for Phase 1b)

Advanced Solid Tumors; HER2-positive Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleHoffmann-La RochePhase 2

trastuzumab (Herceptin, ZN-A-1041 + PHESGO / Herceptin plus Perjeta injection for Phase 1c)

Advanced Solid Tumors; HER2-positive Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleMerus B.V.Phase 2

Zenocutuzumab (Zenocutuzumab)

Breast Cancer Metastatic · Breast Cancer Metastatic

#BreastCancerMetastatic#Antibody#Phase2#항체#면역항체+2
효능 ORR 0%임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

bevacizumab combined with dose dense chemotherapy (bevacizumab combined with dose dense chemotherapy)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

trastuzumab (Herceptin, capecitabine and trastuzumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 2

trastuzumab (Herceptin, carboplatin and paclitaxel and or without trastuzumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleThe Netherlands Cancer InstitutePhase 1

atezolizumab (Tecentriq, carbplatin, cyclophophamide, atezolizumab)

Breast Cancer; Cervix Cancer · Breast Cancer

#BreastCancer#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleGBG Forschungs GmbHPhase 3

epirubicin - cyclophosphamide / docetaxel + bevacizumab (epirubicin - cyclophosphamide / docetaxel + bevacizumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleGBG Forschungs GmbHPhase 3

trastuzumab (Herceptin, epirubicin - cyclophosphamide / docetaxel + trastuzumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleGuangdong Provincial People's H…Phase 3

TCHP (investigator-selected taxane/carboplatin/trastuzumab/pertuzumab, investigator-selected taxane/carboplatin/trastuzumab/pertuzumab (TCHP))

Neoadjuvant Therapies for HER2+ Breast Cancer · HER2

#HER2#Antibody#Phase3#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 3

THP (investigator-selected taxane/trastuzumab/pertuzumab, investigator-selected taxane/trastuzumab/pertuzumab (THP))

Neoadjuvant Therapies for HER2+ Breast Cancer · HER2

#HER2#Antibody#Phase3#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleEli LillyPhase 2

ixabepilone + cetuximab (ixabepilone + cetuximab)

Triple Negative Locally Advanced Non-resectable Breast Cancer; Metastatic Breast Cancer · Triple Negative Locally Advanced Non-res

#TripleNegativeLocallyAdvancedNon#Antibody#Phase2#항체#면역항체+3
효능 ORR 30%임상시험 1상태 ACTIVE
AntibodystalePeking Union Medical College Ho…Phase 3

trastuzumab (Herceptin, lapatinib/herceptin)

HER2-positive Breast Cancer · HER2

#HER2#Antibody#Phase3#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleCytoDyn, Inc.Preclinical

PRO 140 (leronlimab, leronlimab (PRO 140))

TNBC; TNBC - Triple-Negative Breast Cancer · TNBC

#TNBC#Antibody#Preclinical#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleThe Greater Poland Cancer CentrePreclinical

doxorubicin, cyclophosphamide, paclitaxel, trastuzumab, pertuzumab (neoadjuvant treatment, neoadjuvant treatment (doxorubicin, cyclophosphamide, paclitaxel, trastuzumab, pertuzumab))

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleDorte NielsenPhase 2

trastuzumab (Herceptin, oxaliplatin, capecitabine, trastuzumab)

Metastatic Breast Cancer; Liver Metastases · Metastatic Breast Cancer

#MetastaticBreastCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleWiSP Wissenschaftlicher Service…Phase 2

trastuzumab (Herceptin, paclitaxel plus trastuzumab)

Metastatic Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleGuangdong Provincial People's H…Phase 2

trastuzumab (Herceptin, palbociclib and exemestane plus trastuzumab and pyrotinib)

Neoadjuvant Treatment for HER2-positive, ER-positive Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 3

P (pertuzumab, pertuzumab (P))

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 2

trastuzumab (Herceptin, pertuzumab + trastuzumab + nab-paclitaxel)

HER2+ Early or Locally Advanced Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE

8 / 9 페이지

← 이전다음 →